Scientist to Watch

» ecology, cancer, genetics & genomics and biochemistry

Most Recent

Member, Department of Immunology, St. Jude Children’s Research Hospital. Age: 43

0 Comments

Instructor, Department of Systems Biology, University of Texas MD Anderson Cancer Center. Age: 38

1 Comment

image: Jason Holliday: Tree Tracker

Jason Holliday: Tree Tracker

By | February 1, 2016

Associate Professor, Virginia Tech, Department of Forest Resources and Environmental Conservation. Age: 37

0 Comments

image: Yun “Nancy” Huang: Eager for Epigenetics

Yun “Nancy” Huang: Eager for Epigenetics

By | August 1, 2015

Assistant Professor, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston. Age: 35

0 Comments

image: Weiwei Dang: Epigenetics in Aging

Weiwei Dang: Epigenetics in Aging

By | March 1, 2015

Assistant Professor, Huffington Center On Aging, Baylor College of Medicine. Age: 38

0 Comments

image: Doris Bachtrog: Sex Chromosome Wrangler

Doris Bachtrog: Sex Chromosome Wrangler

By | January 1, 2015

Associate Professor, Department of Integrative Biology, University of California, Berkeley. Age: 39

0 Comments

image: Feng Zhang: The Midas of Methods

Feng Zhang: The Midas of Methods

By | August 1, 2014

Core Member, Broad Institute; Investigator, McGovern Institute; Assistant Professor, MIT. Age: 32

0 Comments

image: Matthew Powner: Origin Solver

Matthew Powner: Origin Solver

By | March 1, 2014

Lecturer, Department of Chemistry, University College London. Age: 32

2 Comments

image: Yoav Gilad: Gene Regulator

Yoav Gilad: Gene Regulator

By | October 1, 2013

Professor, Department of Human Genetics, University of Chicago. Age: 38

3 Comments

image: Mary O’Connor: Warming Up

Mary O’Connor: Warming Up

By | June 1, 2013

Assistant Professor, Department of Zoology, University of British Columbia. Age: 34

1 Comment

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech